What We Learned at AACR 2019

We all know that CAR-T therapies and immune checkpoint inhibitors are game-changers for oncology, and both were on display at the American Association for Cancer Research’s annual meeting held in Atlanta last week. Although both therapies have produced spectacular results in some patients, neither work for all patients and efforts must now turn to understanding…